3-((1H-Imidazol-1-yl)methyl)-3-(4-chlorophenyl)-5-(2,6-dichlorophenyl)-2-methylisoxazolidine

Catalog No. :
ACNAJY916
CAS No. :
113614-54-3
Molecular Formula :
C20H18Cl3N3O
Molecular Weight :
422.74

IUPAC Name:3-((1H-imidazol-1-yl)methyl)-3-(4-chlorophenyl)-5-(2,6-dichlorophenyl)-2-methylisoxazolidine

3-((1H-Imidazol-1-yl)methyl)-3-(4-chlorophenyl)-5-(2,6-dichlorophenyl)-2-methylisoxazolidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-((1H-Imidazol-1-yl)methyl)-3-(4-chlorophenyl)-5-(2,6-dichlorophenyl)-2-methylisoxazolidine
IUPAC Name3-((1H-imidazol-1-yl)methyl)-3-(4-chlorophenyl)-5-(2,6-dichlorophenyl)-2-methylisoxazolidine
Molecular FormulaC20H18Cl3N3O
Molecular Weight422.74
SMILESCN1OC(C2=C(Cl)C=CC=C2Cl)CC1(CN1C=CN=C1)C1=CC=C(Cl)C=C1
InChI KeyDLWGYWVYKHEBNZ-UHFFFAOYSA-N
SynonymIsoxazolidine, 3-(4-chlorophenyl)-5-(2,6-dichlorophenyl)-3-(1H-imidazol-1-ylmethyl)-2-methyl-, cis- (9CI)
CAS No.113614-54-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNAJY916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNAJY916 route product structure diagram
    ACNAJY916113614-54-3
Inquiry

2. ACNAJY916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACNAJY916 route product structure diagram
    ACNAJY916113614-54-3
Inquiry

Comments (0)